181 related articles for article (PubMed ID: 36465663)
1. Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study.
Pan C; Deng D; Wei T; Wu Z; Zhang B; Yuan Q; Liang G; Liu Y; Yin P
Front Endocrinol (Lausanne); 2022; 13():1039786. PubMed ID: 36465663
[TBL] [Abstract][Full Text] [Related]
2. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
3. Widely quasi-quantitative analysis enables temporal bile acids-targeted metabolomics in rat after oral administration of ursodeoxycholic acid.
Cao Y; Li W; Gong X; Niu X; Zheng J; Yu J; Li J; Tu P; Song Y
Anal Chim Acta; 2022 Jun; 1212():339885. PubMed ID: 35623780
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
5. The urinary bile acid profiling analysis of asymptomatic hypercholanemia of pregnancy: A pseudo-targeted metabolomics study.
Chen X; Zhang X; Xu B; Cui Y; He Y; Yang T; Shao Y; Ding M
Clin Chim Acta; 2019 Oct; 497():67-75. PubMed ID: 31276634
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
7. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
8. Robust and Comprehensive Targeted Metabolomics Method for Quantification of 50 Different Primary, Secondary, and Sulfated Bile Acids in Multiple Biological Species (Human, Monkey, Rabbit, Dog, and Rat) and Matrices (Plasma and Urine) Using Liquid Chromatography High Resolution Mass Spectrometry (LC-HRMS) Analysis.
Sangaraju D; Shi Y; Van Parys M; Ray A; Walker A; Caminiti R; Milanowski D; Jaochico A; Dean B; Liang X
J Am Soc Mass Spectrom; 2021 Aug; 32(8):2033-2049. PubMed ID: 33826317
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
10. A pseudo-targeted metabolomics study based on serum bile acids profiling for the differential diagnosis of benign and malignant breast lesions.
Luo C; Zhang X; He Y; Chen H; Liu M; Wang H; Tang L; Tu G; Ding M
Steroids; 2021 Nov; 175():108914. PubMed ID: 34481814
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
[TBL] [Abstract][Full Text] [Related]
12. Analysis of eight bile acids in urine of gastric cancer patients based on covalent organic framework enrichment coupled with liquid chromatography-tandem mass spectrometry.
Lyu J; Li H; Yin D; Zhao M; Sun Q; Guo M
J Chromatogr A; 2021 Sep; 1653():462422. PubMed ID: 34348207
[TBL] [Abstract][Full Text] [Related]
13. High serum levels of L-carnitine and citric acid negatively correlated with alkaline phosphatase are detectable in Koreans before gastric cancer onset.
Han Y; Yoo HJ; Jee SH; Lee JH
Metabolomics; 2022 Jul; 18(8):62. PubMed ID: 35900644
[TBL] [Abstract][Full Text] [Related]
14. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characteristics of plasma bile acids in patients with intrahepatic cholestasis of pregnancy-mass spectrometric study.
Zheng Q; Shen L; Zhao D; Zhang H; Liang Y; Zhu Y; Khan NU; Liu X; Zhang J; Lin J; Tang X
Metabolomics; 2021 Sep; 17(10):93. PubMed ID: 34595616
[TBL] [Abstract][Full Text] [Related]
16. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
[TBL] [Abstract][Full Text] [Related]
18. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
[TBL] [Abstract][Full Text] [Related]
19. Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.
Yang L; Xiong A; He Y; Wang Z; Wang C; Wang Z; Li W; Yang L; Hu Z
Chem Res Toxicol; 2008 Dec; 21(12):2280-8. PubMed ID: 19053324
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.
Han X; Wang J; Gu H; Guo H; Cai Y; Liao X; Jiang M
Metabolomics; 2022 Jun; 18(7):43. PubMed ID: 35759044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
